Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - COST OF REVENUE
Cost of Revenue FOLD - Amicus Therapeutics, Inc.
37.3 M
LAST VALUE
4.07%
2 YEAR CAGR
20.98%
5 YEAR CAGR
10.71%
10 YEAR CAGR